Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study

Differences in glucose metabolism among categories of prediabetes have not been systematically investigated. In this longitudinal study, participants (N = 2,111) underwent a 2-h 75-g oral glucose tolerance test (OGTT) at baseline and 48 months. HbA1c was also measured. We classified participants as having isolated prediabetes defect (impaired fasting glucose [IFG], impaired glucose tolerance [IGT], or HbA1c indicative of prediabetes [IA1c]), two defects (IFG+IGT, IFG+IA1c, or IGT+IA1c), or all defects (IFG+IGT+IA1c). β-Cell function (BCF) and insulin sensitivity were assessed from OGTT. At baseline, in pooling of participants with isolated defects, they showed impairment in both BCF and insulin sensitivity compared with healthy control subjects. Pooled groups with two or three defects showed progressive further deterioration. Among groups with isolated defect, those with IGT showed lower insulin sensitivity, insulin secretion at reference glucose (ISRr), and insulin secretion potentiation (P < 0.002). Conversely, those with IA1c showed higher insulin sensitivity and ISRr (P < 0.0001). Among groups with two defects, we similarly found differences in both BCF and insulin sensitivity. At 48 months, we found higher type 2 diabetes incidence for progressively increasing number of prediabetes defects (odds ratio >2, P < 0.008). In conclusion, the prediabetes groups showed differences in type/degree of glucometabolic impairment. Compared with the pooled group with isolated defects, those with double or triple defect showed progressive differences in diabetes incidence.

[1]  Kim M Pfotenhauer,et al.  Classification and Diagnosis of Diabetes. , 2022, Primary care.

[2]  J. Krakoff,et al.  Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans , 2021, Diabetologia.

[3]  R. DeFronzo,et al.  Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance , 2020, Diabetes.

[4]  F. Schick,et al.  Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes , 2020, Nature Medicine.

[5]  W. Rathmann,et al.  Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany , 2020, Acta Diabetologica.

[6]  M. McCarthy,et al.  Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2020, Diabetologia.

[7]  M. McCarthy,et al.  Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2020, Diabetes Care.

[8]  A. Tura,et al.  Insulin clearance is altered in women with a history of gestational diabetes progressing to type 2 diabetes. , 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  L. Smeeth,et al.  Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: The CRONICAS Cohort Study. , 2020, Diabetes research and clinical practice.

[10]  G. Bray,et al.  Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS) , 2019, Diabetes Care.

[11]  Y. Takwoingi,et al.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. , 2018, The Cochrane database of systematic reviews.

[12]  R. DeFronzo,et al.  Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES). , 2018, The lancet. Diabetes & endocrinology.

[13]  Y. Hwang,et al.  Factors associated with regression from prediabetes to normal glucose tolerance in a Korean general population: A community‐based 10‐year prospective cohort study , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[14]  Consortium Bai Rise.  Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp , 2018, Diabetes Care.

[15]  F. Hu,et al.  Genetic variants of gestational diabetes mellitus: a study of 112 SNPs among 8722 women in two independent populations , 2018, Diabetologia.

[16]  Shinya Kuroda,et al.  Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects , 2018, npj Systems Biology and Applications.

[17]  A. Tura,et al.  Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index , 2018, Diabetologia.

[18]  Tao Yang,et al.  Impaired β-cell function and decreased insulin sensitivity in subjects with normal oral glucose tolerance but isolated high glycosylated hemoglobin. , 2017, Endocrine journal.

[19]  G. Reaven,et al.  Adapting to insulin resistance in obesity: role of insulin secretion and clearance , 2018, Diabetologia.

[20]  U. Ekelund,et al.  Physical Activity and Improvement of Glycemia in Prediabetes by Different Diagnostic Criteria , 2017, The Journal of clinical endocrinology and metabolism.

[21]  K. Joshipura,et al.  Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population , 2017, Diabetes/metabolism research and reviews.

[22]  A. Tura,et al.  Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin. , 2017, Endocrine journal.

[23]  F. Arturi,et al.  One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. , 2015, The Journal of clinical endocrinology and metabolism.

[24]  Jimmy D Bell,et al.  Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium , 2014, Diabetologia.

[25]  A. Tura,et al.  Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic , 2014, Diabetologia.

[26]  Dalong Zhu,et al.  Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population , 2014, Acta Diabetologica.

[27]  T. Abe,et al.  The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. , 2013, The Journal of clinical investigation.

[28]  G. Marchesini,et al.  Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. , 2013, The Journal of clinical endocrinology and metabolism.

[29]  K. Watson,et al.  Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study , 2012, The Lancet.

[30]  F. Arturi,et al.  Cardiometabolic Risk Profiles and Carotid Atherosclerosis in Individuals With Prediabetes Identified by Fasting Glucose, Postchallenge Glucose, and Hemoglobin A1c Criteria , 2012, Diabetes Care.

[31]  F. Arturi,et al.  Insulin Sensitivity, β-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels , 2012, Diabetes Care.

[32]  J. Holst,et al.  Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes , 2012, Diabetologia.

[33]  F. Arturi,et al.  Cardiometabolic Risk Pro fi les and Carotid Atherosclerosis in Individuals With Prediabetes Identi fi ed by Fasting Glucose , Postchallenge Glucose , and Hemoglobin A 1 c Criteria , 2012 .

[34]  G. Marchesini,et al.  Pathogenetic Mechanisms and Cardiovascular Risk Differences between HbA 1 c and oral glucose tolerance test for the diagnosis of glucose tolerance , 2012 .

[35]  S. Keinänen-Kiukaanniemi,et al.  Limited Overlap Between Intermediate Hyperglycemia as Defined by A1C 5.7–6.4%, Impaired Fasting Glucose, and Impaired Glucose Tolerance , 2011, Diabetes Care.

[36]  C. Kramer,et al.  Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673 , 2011, Diabetes Care.

[37]  A. Wägner,et al.  Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test , 2010, Diabetes Care.

[38]  K. Qureshi,et al.  Comparative Evaluation of Whole Body and Hepatic Insulin Resistance Using Indices from Oral Glucose Tolerance Test in Morbidly Obese Subjects with Nonalcoholic Fatty Liver Disease , 2010, Journal of obesity.

[39]  C. Östenson,et al.  Factors determining normalization of glucose intolerance in middle‐aged Swedish men and women: a 8–10‐year follow‐up , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[40]  R. DeFronzo,et al.  One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes , 2008, Diabetes Care.

[41]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[42]  Andrea Tura,et al.  Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. , 2002, Diabetes.